The effect of recombinant human intrinsic factor on the uptake of vitamin B12 in patients with evident vitamin B12 deficiency

Haematologica. 2006 Jun;91(6):805-8. Epub 2006 May 16.

Abstract

We report on the use of recombinant human intrinsic factor (rhIF) in a new vitamin B12 absorption test. Holotranscobalamin (holoTC) was measured before and 24 hours after intake of three 9-mg doses of vitamin B12 (B12) and again 24 hours after intake of the same dose of B12 together with rhIF (rhIF-B12). Nine patients with evident vitamin B12 deficiency had a significantly higher increase in holoTC after intake of rhIF-B12 than after intake of B12. Twenty-eight patients with suspected vitamin B12 deficiency showed no additional increase in holoTC after intake of rhIF-B12. We conclude that rhIF promotes B12 absorption among patients with evident vitamin B12 deficiency.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biological Transport
  • Humans
  • Intestinal Absorption*
  • Intrinsic Factor / therapeutic use*
  • Recombinant Proteins / therapeutic use
  • Vitamin B 12 / pharmacokinetics*
  • Vitamin B 12 / therapeutic use
  • Vitamin B 12 Deficiency / drug therapy*

Substances

  • Recombinant Proteins
  • Intrinsic Factor
  • Vitamin B 12